MRTX

Mirati Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD58.70

-0.10 (-0.17%)

Company Profile

CEO

Charles M. Baum

IPO Date

2013-07-15

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$58.86

Prev. Close

$58.80

Day Low

$58.54

Day High

$58.99

52W Low

$27.30

52W High

$64.41

Market Cap

$4.12B

Volume

20.96M

News SentimentBullish

Articles

Avg Positive

46.0%

Avg Negative

10.5%

Avg Neutral

43.5%

News Feed

Mirati's (MRTX) Adagrasib Gets Breakthrough Therapy Status

Zacks Investment Research·6/28/2021·↑ positive

Mirati's KRAS Inhibitor Receives FDA Breakthrough Tag For Lung Cancer Harboring KRAS Mutation

Benzinga·6/25/2021·↑ positive

Mirati Therapeutics' Adagrasib Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Patients with Advanced Non-Small Cell Lung Cancer Harboring the KRAS G12C Mutation